Open original FDA record ↗Recall record
- FDA identifier
- Z-2298-2020
- Company in FDA record
- Hardy Diagnostics
- FDA classification date
- Jun 9, 2020
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
False Positive results due to the MSSA (methicillin-susceptible) strain Staphylococcus aureus (ATCC 29213) breakthrough when this strain should have been inhibited.
Source facts
- Action
- On 11/14/2019, the firm sent a notification of recall letter to customers, informing them of the performance issue of the device lot of the breakthrough on firm's differential chromogenic medium. The customers were advised to discard the remaining stock, and notify the Technical Services Department. If the customer would like replacement or credit, contact Technical Services Department or via e-mail at TechService@HardyDiagnostics.com, or 800-266-2222 option 2 or ext. 5658.
- Initiated
- 2019-11-14
- Root cause
- Nonconforming Material/Component
- Terminated
- 2021-04-28
- Distribution
- U.S. Distribution in the states of WI, CA, WA, IA, MT, UT, AZ, WY, KS, MO, OR, TX, VI, including PR and Guam. OUS: British Virgin Islands, Kenya,
- Recall number
- Z-2298-2020
- Recall status
- Terminated
- CDRH record ID
- 180773
- FDA classified
- 2020-06-09
- Recall event number
- 85412